AzTrials
AzTrials

Caries Class IiNCT06833177

Clinical Evaluation of Ceramage Inlays Cemented With Beautilink Self-Adhesive Resin Cement Versus Rely X Resin Cement in Carious Posterior Teeth

A study testing Beautilink SA cement and RelyX resin cement in people with Caries Class Ii, run by Cairo University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Minimally invasive bonded partial restorations have become a crucial component of contemporary dental treatments. They address the shortcomings of direct restorations and provide patients with a less damaging alternative to full coverage restorations, which can be more harmful to the dental structure. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Caries Class Ii
What is being tested?
Beautilink SA cement and RelyX resin cement
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
11 Nov 2025to 20 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Posterior vital tooth with a large carious lesion (ICDAS 4/5)
  • Posterior vital tooth with a broken restoration that should be replaced (ICDAS 4-7/5-7).
  • Vital, periodontally sound and with positive reaction to cold stimulus.
  • Fully erupted posterior molar in normal functional occlusion with natural antagonist and adjacent teeth.

Who cannot join

  • Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
  • Non-vital teeth, Fractured or cracked teeth.
  • Endodontically treated teeth.
  • Periodontally affected teeth.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo, Cairo Governorate, 002

Other trials in Egypt

About this study

Official title: Eighteen Months Clinical Evaluation of Hybrid Ceramic Inlays Cemented With Giomer Based Self-adhesive Resin Cement Versus Resin-based Cement in Carious Posterior Teeth: Randomized Controlled Clinical Trial

Minimally invasive bonded partial restorations have become a crucial component of contemporary dental treatments. They address the shortcomings of direct restorations and provide patients with a less damaging alternative to full coverage restorations, which can be more harmful to the dental structure. Indirect inlay composite restorations have become a popular choice in restorative dentistry due to their aesthetic appeal and durability. These restorations allow for the preservation of tooth structure while utilizing the mechanical advantages of modern adhesive technology, which can reinforce the weakened compromised tooth structure.

The use of different adhesive materials with Ceramage can significantly influence the success of the restoration. Adhesive materials play a crucial role in ensuring a strong bond between the indirect restoration and the tooth structure. Additionally, the choice of adhesive material can also affect the ease of the cementation process. Self-adhesive resin cement simplifies the procedure by eliminating the need for separate bonding agents, thus reducing the risk of technique sensitivity which can lead to more consistent clinical outcomes and improved patient satisfaction.

Overall, the combination of Ceramage with appropriate adhesive materials offers a reliable and aesthetically pleasing solution for indirect inlay composite restorations, enhancing both the biological, functional and esthetic outcomes of dental treatments.

Conditions
Caries Class Ii
Being tested
Beautilink SA cement, RelyX resin cement
Keywords
Inlays, Ceramage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Beautilink SA cementOther

    According to the manufacturer's instructions (BeautiLink SA - Shofu USA)

    • To enhance the adhesion, adhesive bonding agent BeautiBond Xtreme, Shofu will be applied on the tooth and cured according to the manufacturer's instructions.
    • Press the plunger of the auto-mix syringe of Beautilink SA to dispence the cement on the adhesive surface of the restoration.
    • Seat the restoration in the cavity and apply proper pressure after using Teflon to protect the adjacent teeth and help in the removal of the excess material.
    • Light-cure the excess material for 1-2 sec with a light-curing unit followed by removal of the tack-cured material with a probe.
    • Using a light-curing unit to cure each surface and marginal areas for 10 seconds. For areas where the light cannot reach, or when using opaque cement, hold the restoration in place for approximately 5 minutes after light-curing to allow for chemical curing.
  • RelyX resin cementOther

    According to the manufacturer's instructions (Espe).

    • To enhance the adhesion, adhesive bonding agent 3M™ Scotchbond™ Universal Plus Adhesive will be applied on the tooth and cured according to the manufacturer's instructions.
    • Application of 3M™RelyX™ Universal Resin Cement into the cavity
    • Seat the restoration in the cavity and apply proper pressure after using Teflon to protect the adjacent teeth and help in the removal of the excess material.
    • Light-cure the excess material for 2-3 sec with a light-curing unit followed by removal of the tack-cured material with a probe.
    • Using a light-curing unit to cure each surface and marginal areas for 10 seconds. For areas where the light cannot reach, or when using opaque cement, hold the restoration in place for approximately 6 minutes after light-curing to allow for chemical curing.
Study groups in NCT06833177
Study groupRoleWhat they receive
Cementation via Beautilink SA cementExperimentalCeramage inlays will be cemented using Beautilink SA cement * To enhance the adhesion, adhesive bonding agent BeautiBond Xtreme, Shofu will be applied on the tooth and cured according to the manufacturer's instructions. * Press the plunger of the auto-mix syringe of Beautilink SA to dispence the cement on the adhesive surface of the restoration. * Using a light-curing unit to cure each surface and marginal areas for 10 seconds. For areas where the light cannot reach, or when using opaque cement, hold the restoration in place for approximately 5 minutes after light-curing to allow for chemical curing.
Receives: Other: Beautilink SA cement
Cementation via RelyX resin cementActive comparatorCeramage inlays will be cemented using RelyX resin cement * To enhance the adhesion, adhesive bonding agent 3M™ Scotchbond™ Universal Plus Adhesive will be applied on the tooth and cured according to the manufacturer's instructions. * Application of 3M™RelyX™ Universal Resin Cement into the cavity * Using a light-curing unit to cure each surface and marginal areas for 10 seconds. For areas where the light cannot reach, or when using opaque cement, hold the restoration in place for approximately 6 minutes after light-curing to allow for chemical curing.
Receives: Other: RelyX resin cement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Performance assessing Biological, Mechanical and Esthetic Parameters Using Modified USPHS Criteria

    Alpha being the best results and Charlie being the worst results

    Measured: T0: 12 months T1: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2025
  2. Study start11 Nov 2025
  3. Primary completion11 May 2027 (estimated)
  4. Study completion20 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06833177
Sponsor's protocol ID
20091993
Status last verified
Apr 2026
First submitted
13 Feb 2025
Last updated
7 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Beautilink SA cement and RelyX resin cement in people with Caries Class Ii, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Performance assessing Biological, Mechanical and Esthetic Parameters Using Modified USPHS Criteria (time frame: T0: 12 months T1: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in